Patients shift spending to longevity treatments and regenerative skincare

Aesthetic consumer spending is shifting away from discretionary treatments toward longevity, maintenance, and skin-quality procedures, meaning clinics must adjust their service and retail mix to capture these shifting budgets. Data from Guidepoint Qsight shows total patient spending rose nine percent year-over-year to 7.8 billion dollars in Q2. However, this market growth is unevenly distributed. While surgical spending jumped 19 percent and neurotoxins grew nine percent, nonsurgical body contouring is declining. This drop is largely driven by patients opting for GLP-1 weight-loss medications instead of device-based fat reduction treatments. Meanwhile, interest in cellular health is spiking. Regenerative skincare treatments in clinics grew 20 percent, and retail sales of take-home regenerative products surged by 71 percent. For practice owners, these numbers suggest a clear reallocation of resources. Rather than investing heavily in new body contouring platforms, clinicians should focus capital on expanding their regenerative skincare offerings, optimizing home-care retail pipelines, and reinforcing foundational injectable maintenance treatments that offer patients clear, long-term value.

Source: MedEsthetics, https://www.medestheticsmag.com/skin-care/news/22026010/aesthetic-consumers-are-reallocating-spending-toward-longevity-maintenance-and-skin-health